 |
|
|
Laurence Greenhill, M.D.
RUANE PROF CLIN PSYI
Director, Local Research Unit of Pediatric Psychopharmacology,
New York State Psychiatric Institute
|
|
|
|
|
|
|
|
|
Dr. Greenhill is a Child and Adolescent Psychiatrist who is board certified in child (3/76, #888)and adult (5/75, #13930)from his training at the Albert Einstein College of Medicine. Dr. Greenhill is Ruane Professor of Clinical Psychiatry. He is engaged in research on the safety and efficacy of medications to ameliorate psychiatric symptoms in youth, with specific projects in determining the long-term benefits of medication treatments on preschool children with Attention-Deficit / Hyperactivity Disorder (ADHD) and conducting research on the efficacy of different types of treatment on depressed adolescents with suicidal behavior. He is currently the President-Elect of the American Academy of Child & Adolescent Psychiatry.
|
 |
Undergraduate: Columbia College, A.B., 1963
Medical School: Albert Einstein College of Medicine, M.D., 1967
Internship: Bronx Municipal Hospital Center, Pediatrics, 1967 - 1968
Residency: Bronx Municipal Hospital Center, Psychiatry, 1968 - 1972
Residency: Bronx Municipal Hospital Center, Child Psychiatry, 1962 - 1974
Fellowship: National Institute of Mental Health, 1970, 1968
Board Certifications: PSYI #13930, Child PSYI #888, Private Practice Assessment 12/03
Subspeciality Certifications: Child PSYI #888
|
 |
• Child and Adolescent Psychiatry
|
 |
Address:
NYS Psychiatric Institute
Room 2B-2307 Unit/Box:Child Psychiatry
1051 Riverside Drive
New York, NY 10032
Phone: 212-543-5340
Fax: 212-543-6660
llg2@columbia.edu
|
 |
| Dr. Greenhill is engaged in research on the safety and efficacy of medications to ameliorate psychiatric symptoms in youth, with specific projects in determining the long-term benefits of medication treatments on preschool children with Attention-Deficit / Hyperactivity Disorder (ADHD) and conducting research on the efficacy of different types of treatment on depressed adolescents with suicidal behavior. He is currently the President-Elect of the American Academy of Child & Adolescent Psychiatry.
|
 |
1. Greenhill LL, Posner K, Vaughn BS, Kratochvil CJ: Attention Deficit Hyperactivity Disorder in Preschoolers. Child Adolescent Psychiatric Clinics of North America 2008;17(2): 347-366
1. Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, Owens J, Scahill LD, Scheeringa MS, Stafford B, Wise B, Zeanah C: Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatry 2007;46(12): 1532-1572
1. Casey BJ, Epstein JN, Buhle J, Liston C, Davidson MC, Tonev ST, Spicer J, Niogi S, Millner AJ, Riess A, Garrett A, Hinshaw SP, Greenhill LL< SHafritz KM, Vitolo A, Kotler LA, Jarrett MA, Glover G: Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD. American Journal of Psychiatry 2007;164(11): 1729-1736
1. Findling RL, Greenhill LL, McNamara NK, Demeter CA, Kotler LA, O'Riordan MA, Myers C, Reed MD: Venlafaxine in the tratment of children and adolescents with attention-deficit hyperactivity Disorder. Jounral of Child & Adolescent Psychopharmacology 2007;17(4): 433-450
1. Greenhill LL, Newcorn JH, Gao H, Feldman PD: Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine. J Amer Acad Child Adolesc Psychiatry 2007;46 (5): 566-572
|
 |
|
FACULTY ONLY
|
|
|
